Navigation Links
Teva Releases Second Video in Year of Affordable Healthcare Campaign
Date:2/24/2009

WASHINGTON, Feb. 24 /PRNewswire-USNewswire/ -- Teva Pharmaceuticals USA, the leading generic pharmaceutical company, today released the second in a series of videos as part of the "Year of Affordable Healthcare" campaign.

The video, entitled "Where Am I?" (available at www.yearofaffordablehealth.com/gallery) is meant to illustrate the important savings generic drugs have produced for everyday Americans since the passage of Waxman-Hatch 25 years ago.

Teva's "Year of Affordable Healthcare" is a nationwide campaign to recognize the important role that generic drugs play and commemorates the 25th anniversary of the landmark Waxman-Hatch Act which created the modern generic drugs industry and has resulted in billions of dollars of savings.

The Year of Affordable Healthcare campaign was launched on February 10, 2009 with the release of a national poll that finds many Americans, due to the economic crisis, have skipped their doses of medication to save money. There is strong support among respondents for increasing the use of generic medicines as a way to reform the system and reduce costs.

For more information, visit our website at: www.yearofaffordablehealth.com.

About Teva

Teva USA is a wholly-owned subsidiary of Teva Pharmaceutical Industries Ltd., one of the largest generic pharmaceutical companies in the world and among the top 20 pharmaceutical companies.


'/>"/>
SOURCE Teva Pharmaceuticals USA
Copyright©2009 PR Newswire.
All rights reserved

Page: 1

Related medicine news :

1. DaVita Releases Top Clinical Priorities for 2009
2. Carestream Molecular Imaging Releases Western Blot Kits For Added Convenience, Better Performance
3. Moet & Chandon Releases Grand Vintage 1929 Magnum Commemorating First-Ever Academy Awards(R) To Benefit Motion Picture & Television Fund
4. PA DEP Releases Quarterly Mammography Inspections
5. Thomson Reuters Releases 2009 Patent Focus Report
6. Lumension Releases Annual Cybersecurity Report in Tandem with "Optimal Security" Blog Launch
7. Golden Meditech Releases FY2008/09 Q3 Results
8. Third-Party Audits: EHA Consulting Group Releases Comments on Food Safety Consultant Auditors' Qualifications and Competencies
9. MainConcept Releases New Codec SDK 8.0
10. ADA releases updated position statement on weight management
11. Techne Corporation Releases Unaudited Second Quarter Results for Fiscal Year 2009
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2017)... (PRWEB) , ... October 13, 2017 , ... Many families ... However, many long-term care insurance companies have a waiver for care if the client ... elimination period, when the family pays for care, is often waived, so the benefits ...
(Date:10/13/2017)... ... October 13, 2017 , ... Yisrayl Hawkins, Pastor and ... explains one of the most popular and least understood books in the Holy Scriptures, ... puzzling descriptions that have baffled scholars for centuries. Many have tossed it off as ...
(Date:10/13/2017)... ... ... “America On The Brink”: the Christian history of the United States and ... of published author, William Nowers. Captain Nowers and his wife, Millie, have six ... years in the Navy. Following his career as a naval aviator and carrier ...
(Date:10/12/2017)... , ... October 12, 2017 , ... ... to meet the demand of today’s consumer and regulatory authorities worldwide. From Children’s ... experts and tested to meet the highest standard. , These products are ...
(Date:10/12/2017)... ... October 12, 2017 , ... ... system that we intend to develop to enable prevention of a major side ... severe hearing loss, especially in pediatric patients. For cisplatin, hearing loss is FDA ...
Breaking Medicine News(10 mins):
(Date:9/27/2017)... MIAMI , Sept. 27, 2017  Commended for their ... recent notable awards. Ranked as number one in the South ... ninth time in Inc. 5000 yearly list, the national specialty ... CEO, Armando Bardisa will soon be honored by ... Set to receive his award ...
(Date:9/23/2017)... Sept. 22, 2017 Janssen Biotech, Inc. (Janssen) ... letter from the U.S. Food and Drug Administration (FDA) ... sirukumab for the treatment of moderately to severely active ... clinical data are needed to further evaluate the safety ... active RA. ...
(Date:9/19/2017)... --  ZirMed Inc ., a recognized leader in cloud-based revenue ... been ranked #1 by its users for the seventh consecutive ... Survey. ZirMed was recognized as the top-ranked end-to-end revenue cycle ... over 200 beds and holds one of the longest #1 ... ...
Breaking Medicine Technology: